Small-cap equities continue to draw investor attention amid shifting expectations around interest-rate policy, domestic economic strength, and the possibility of market leadership expanding beyond mega-cap technology names. IJR and VTWO stand out as two popular vehicles for this exposure. While both target the U.S. small-cap segment, they rest on indexes with distinct construction methods. This comparison examines whether the funds function as close substitutes or serve somewhat different objectives.
IJR is a passively managed fund designed to follow the S&P SmallCap 600 Index. The index applies a profitability screen that requires positive earnings in the most recent quarter and over the trailing four quarters, in addition to liquidity criteria. This approach tends to exclude more speculative, early-stage companies and favors established businesses. The fund holds roughly 600 stocks, with notable sector weights in financial services, industrials, information technology, and consumer discretionary. Recent top holdings have included CORT, GKOS, FORM, VSAT, and QRVO. Its net expense ratio of 0.06% ranks among the lowest in the category. I also checked this using Tickeron’s AI Screener to see how the holdings align with broader industry trends.
VTWO passively tracks the Russell 2000 Index, which includes approximately the 2,000 smallest companies among the 3,000 largest U.S. equities. Without a profitability filter, the index incorporates a larger share of unprofitable and early-stage firms, especially in biotechnology. The fund holds about 2,000 stocks, with sector concentrations in industrials, healthcare, financial services, and technology. Recent top holdings have featured MOG.A, FROG, UMBF, CYTK, and BE. Like IJR, it carries a net expense ratio of approximately 0.06%.
Both ETFs respond to the same broad economic drivers. Small-cap companies often carry more floating-rate debt and derive a greater portion of revenue domestically, leaving them sensitive to rate expectations and U.S. demand. From what I see, rotations into small caps have occurred when rate-cut prospects strengthen and earnings participation widens. Sector differences matter as well: VTWO’s healthcare emphasis links it to biotech funding and regulatory outcomes, while IJR’s financial and industrial tilt connects it to bank margins, manufacturing data, and infrastructure trends.
The two funds have generally moved together in recent periods, yet their risk characteristics differ. The S&P 600 profitability screen removes many loss-making names, so IJR has shown modestly lower volatility and steadier positioning than VTWO, which includes more high-beta, unprofitable growth stocks. Sector rotations highlight these distinctions: when financials and industrials lead, IJR tends to benefit; when speculative healthcare names surge, VTWO can show short-term outperformance. Over full cycles, IJR’s structure has often delivered smoother results for investors seeking quality exposure.
I also reviewed relative positioning with Tickeron’s AI Trend Prediction Engine to gauge how sector tilts might evolve. One thing that stands out is how these tools help surface patterns across similar ETFs without replacing core fundamental analysis.
Structural factors lead Tickeron’s AI to favor IJR over VTWO. The profitability requirement supports a higher-quality, more defensive portfolio that has historically delivered smoother risk-adjusted outcomes. With comparable costs and a sector mix weighted toward financials, industrials, and established technology, IJR offers a more resilient profile across varying conditions. VTWO remains suitable for those seeking maximum breadth and biotech exposure, yet the model assigns higher probability-weighted preference to IJR for consistency and trend resilience.
I regularly turn to Tickeron’s AI Screener when comparing ETFs like these. It lets me filter by industry, market cap, technical signals, and performance metrics in one place, which helps confirm how IJR’s quality screen stacks up against VTWO’s broader approach. The tool has become a practical part of my workflow for spotting relative strengths without adding extra steps to the process.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
IJR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 16, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In 40 of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 87%.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IJR as a result. In 83 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
IJR moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IJR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The RSI Indicator entered the oversold zone -- be on the watch for IJR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The 10-day moving average for IJR crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
Following a +3.08% 3-day Advance, the price is estimated to grow further. Considering data from situations where IJR advanced for three days, in 240 of 290 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
IJR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 213 of 265 cases where IJR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 80%.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows